Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 2881 AL 2895

Common Genetic Factors and Pathways in Alzheimer's Disease and Ischemic Stroke: Evidences from GWAS

Dong W, Huang Y.

Genes (Basel). 2023 Jan 30;14(2):353. doi: 10.3390/genes14020353.

Dementia Care Competency Model for Higher Education: A Pilot Study

Josephsen J, Ketelsen K, Weaver M, Scheuffele H.

Int J Environ Res Public Health. 2023 Feb 11;20(4):3173. doi: 10.3390/ijerph20043173.

The Nerve Growth Factor Receptor (NGFR/p75(NTR)): A Major Player in Alzheimer's Disease

Bruno F, Abondio P, Montesanto A, Luiselli D, Bruni AC, Maletta R.

Int J Mol Sci. 2023 Feb 6;24(4):3200. doi: 10.3390/ijms24043200.

How Can Insulin Resistance Cause Alzheimer's Disease?

Yoon JH, Hwang J, Son SU, Choi J, You SW, Park H, Cha SY, Maeng S.

Int J Mol Sci. 2023 Feb 9;24(4):3506. doi: 10.3390/ijms24043506.

Alzheimer's Disease: An Updated Overview of Its Genetics

Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodríguez I, Cadena-Suárez AR, Sánchez-Garibay C, Pozo-Molina G, Méndez-Catalá CF, Cardenas-Aguayo MD, Diaz-Cintra S, Pacheco-Herrero M, Luna-Muñoz J, Soto-Rojas LO.

Int J Mol Sci. 2023 Feb 13;24(4):3754. doi: 10.3390/ijms24043754.

Neurotransmitters in Prevention and Treatment of Alzheimer's Disease

Yang Z, Zou Y, Wang L.

Int J Mol Sci. 2023 Feb 14;24(4):3841. doi: 10.3390/ijms24043841.

Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid β

Vogt AS, Jennings GT, Mohsen MO, Vogel M, Bachmann MF.

Int J Mol Sci. 2023 Feb 15;24(4):3895. doi: 10.3390/ijms24043895.

Gut Microbiota and Alzheimer's Disease: How to Study and Apply Their Relationship

Nguyen NM, Cho J, Lee C.

Int J Mol Sci. 2023 Feb 17;24(4):4047. doi: 10.3390/ijms24044047.

The Prevention of Inflammation and the Maintenance of Iron and Hepcidin Homeostasis in the Gut, Liver, and Brain Pathologies

Kania B, Sotelo A, Ty D, Wisco JJ.

J Alzheimers Dis. 2023;92(3):769-789. doi: 10.3233/JAD-220224.

Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study

Ding P, Gorenflo MP, Zhu X, Xu R.

J Alzheimers Dis. 2023;92(3):989-1000. doi: 10.3233/JAD-220787.

Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments

Andjelkovic AV, Situ M, Citalan-Madrid AF, Stamatovic SM, Xiang J, Keep RF.

Stroke. 2023 Mar;54(3):661-672. doi: 10.1161/STROKEAHA.122.040578. Epub 2023 Feb 27.

Emerging Roles of Endothelial Nitric Oxide in Preservation of Cognitive Health

Katusic ZS, d'Uscio LV, He T.

Stroke. 2023 Mar;54(3):686-696. doi: 10.1161/STROKEAHA.122.041444. Epub 2023 Feb 27.

Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects

Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE.

Inflammopharmacology. 2023 Jun;31(3):1107-1115. doi: 10.1007/s10787-023-01163-7. Epub 2023 Feb 28.

Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Dubois B, López-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S, Venger O, Vermersch P, Moussy A, Mansfield CD, Hermine O, Tsolaki M; AB09004 Study Group Investigators.

Alzheimers Res Ther. 2023 Feb 28;15(1):39. doi: 10.1186/s13195-023-01169-x.

Lecanemab: First Approval

Hoy SM.

Drugs. 2023 Mar;83(4):359-365. doi: 10.1007/s40265-023-01851-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias